Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK prescribing

This article was originally published in The Tan Sheet

Executive Summary

The British Medical Association has called for an "urgent meeting" with British Health Secretary Patricia Hewitt following the UK's announcement to grant prescribing powers to nurses and pharmacists. Hewitt said Nov. 10 that nurses and pharmacists will be afforded prescribing rights for any medical condition, excluding controlled drugs, beginning in Spring 2006 if they complete additional training (1"The Tan Sheet" Nov. 21, 2005, In Brief). "It is difficult to see how healthcare professionals who are not trained to diagnose disease can safely prescribe appropriate treatment," BMA Chairman James Johnson states in a release. Central Consultants & Specialists Committee Chairman Paul Miller called the decision an "irresponsible and dangerous move. Patients will suffer. I would not have me or my family subject to anything other than the highest level of care and prescribing, which is that provided by a fully trained doctor"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098880

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel